Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sensus Healthcare Inc (SRTS)

Sensus Healthcare Inc (SRTS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 103,601
  • Shares Outstanding, K 16,497
  • Annual Sales, $ 26,430 K
  • Annual Income, $ -2,020 K
  • 60-Month Beta -0.21
  • Price/Sales 3.92
  • Price/Cash Flow N/A
  • Price/Book 3.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.05
  • Number of Estimates 4
  • High Estimate 0.02
  • Low Estimate -0.07
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -66.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.75 +33.89%
on 07/25/19
6.46 -1.62%
on 08/16/19
+1.01 (+18.88%)
since 07/16/19
3-Month
4.75 +33.89%
on 07/25/19
6.46 -1.62%
on 08/16/19
+0.96 (+17.78%)
since 05/16/19
52-Week
4.75 +33.89%
on 07/25/19
9.23 -31.09%
on 03/15/19
-0.75 (-10.55%)
since 08/16/18

Most Recent Stories

More News
Sensus Healthcare Reports Second Quarter 2019 Financial Results

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological...

SRTS : 6.36 (+1.27%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management...

SRTS : 6.36 (+1.27%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare to Present at the 20th Annual B. Riley FBR Investor Conference

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe...

SRTS : 6.36 (+1.27%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare Reports First Quarter 2019 Financial Results

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces financial results...

SRTS : 6.36 (+1.27%)
PINC : 38.73 (+0.60%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been awarded a group purchasing agreement for Brachytherapy Products...

SRTS : 6.36 (+1.27%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare to Host First Quarter 2019 Financial Results and Business Update Conference Call on May 9, 2019

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management...

SRTS : 6.36 (+1.27%)
SRTSU : 6.45 (-0.77%)
Sensus Healthcare Signs R&D Agreement to Collaborate with Perelman School of Medicine at the University of Pennsylvania on World's First Sculptura(TM) Intraoperative Radiation Therapy System

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, today announced that the Company has signed a research and development...

SRTS : 6.36 (+1.27%)
SRTSU : 6.45 (-0.77%)
Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare's Superficial Radiation Therapy

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in non-invasive treatments for both oncological and non-oncological conditions, announced today topline results from a five-year...

SRTS : 6.36 (+1.27%)
SRTSU : 6.45 (-0.77%)
Consolidated Research: 2019 Summary Expectations for ZIOPHARM Oncology, Airgain, Liquidity Services, Kindred Biosciences, Landmark Infrastructure Partners LP, and Sensus Healthcare -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of ZIOPHARM Oncology Inc (NASDAQ:ZIOP),...

KIN : 7.28 (+4.45%)
AIRG : 11.80 (+1.81%)
LQDT : 6.67 (+4.38%)
SRTS : 6.36 (+1.27%)
LMRK : 16.27 (+0.25%)
ZIOP : 5.06 (+0.20%)
Sensus Healthcare to Present at the 31st Annual ROTH Conference

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe...

SRTS : 6.36 (+1.27%)
SRTSU : 6.45 (-0.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

See More Share

Trade SRTS with:

Business Summary

Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare,...

See More

Key Turning Points

2nd Resistance Point 6.55
1st Resistance Point 6.46
Last Price 6.36
1st Support Level 6.27
2nd Support Level 6.18

See More

52-Week High 9.23
Fibonacci 61.8% 7.52
Fibonacci 50% 6.99
Fibonacci 38.2% 6.46
Last Price 6.36
52-Week Low 4.75

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar